See also this year's filing and all EDGAR filings for this company.
PDF Report 0001742927_2021_REVIVA_PHARMACEUTICALS_HOLDINGS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001742927')"} |
Graph
Absolute values for 0001742927, REVIVA PHARMACEUTICALS HOLDINGS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 8,762,278 |
| 4 | LiabilitiesCurrent | 1,008,046 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,288,482 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,139,501 |
| 9 | ResearchAndDevelopmentExpense | 295,150 |
| 10 | remainder_Expenses | 800 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,347,937 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,762,278 |
| 1 | Liabilities | 3,296,528 |
| 2 | Expenses | 2,435,451 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 5,465,750 |
| 5 | NetIncome | -3,783,388 |
| 6 | ComprehensiveNetIncome | -3,783,388 |
| 7 | BaseVar | 7,921,097 |
| 8 | EconomicCapitalRatio | 0.932 |